Prestige Consumer Healthcare Inc. (PBH): Cash & Equivalents
$63.87M
As of 2026-03-31
$89.13M
As of 2026-06-30
+3.0%
3-year compound annual growth
+14.6%
5-year compound annual growth
+8.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2026-03-31 | $63.87M | -34.8% | 2026-05-14, Balance as of period end |
| 2025-03-31 | $97.88M | +110.6% | 2026-05-14, Balance as of period end |
| 2024-03-31 | $46.47M | -20.6% | 2025-05-09, Balance as of period end |
| 2023-03-31 | $58.49M | +115.2% | 2024-05-15, Balance as of period end |
| 2022-03-31 | $27.18M | -15.8% | 2023-05-05, Balance as of period end |
| 2021-03-31 | $32.30M | -65.9% | 2022-05-06, Balance as of period end |
| 2020-03-31 | $94.76M | +244.2% | 2021-05-07, Balance as of period end |
| 2019-03-31 | $27.53M | -15.4% | 2020-05-08, Balance as of period end |
| 2018-03-31 | $32.55M | -22.2% | 2019-05-13, Balance as of period end |
| 2017-03-31 | $41.85M | +53.7% | 2018-05-10, Balance as of period end |
| 2016-03-31 | $27.23M | +27.7% | 2018-05-10, Balance as of period end |
| 2015-03-31 | $21.32M | -24.8% | 2017-05-17, Balance as of period end |
| 2014-03-31 | $28.33M | +80.8% | 2016-05-17, Balance as of period end |
| 2013-03-31 | $15.67M | -17.6% | 2015-05-14, Balance as of period end |
| 2012-03-31 | $19.02M | +42.6% | 2014-05-19, Balance as of period end |
| 2011-03-31 | $13.33M | -67.6% | 2013-05-17, Balance as of period end |
| 2010-03-31 | $41.10M | n/a | 2012-05-18, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $63.87M | -34.8% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $177.69M | -44.4% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $198.69M | +98.7% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $195.00M | -38.9% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $372.26M | +53.8% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $285.58M | +97.1% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $752.50M | +66.1% |
| Alkermes plc. (ALKS) | 2025-12-31 | $388.57M | +33.5% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $61.42M | -9.7% |
Compare PBH, ACAD, MDGL, INDV side by side · Screen every company in Pharmaceutical Preparations ↗